Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

BUY
$47.08 - $55.16 $142,369 - $166,803
3,024 New
3,024 $147,000
Q1 2023

May 11, 2023

BUY
$36.57 - $58.29 $149,425 - $238,172
4,086 Added 502.58%
4,899 $272,000
Q4 2022

Jan 24, 2023

BUY
$34.17 - $47.91 $444 - $622
13 Added 1.63%
813 $33,000
Q3 2022

Nov 04, 2022

SELL
$36.93 - $56.68 $127,888 - $196,282
-3,463 Reduced 81.23%
800 $35,000
Q2 2022

Jul 22, 2022

SELL
$28.13 - $44.54 $566,847 - $897,525
-20,151 Reduced 82.54%
4,263 $151,000
Q1 2022

May 09, 2022

SELL
$30.32 - $91.33 $736,048 - $2.22 Million
-24,276 Reduced 49.86%
24,414 $993,000
Q4 2021

Feb 15, 2022

SELL
$86.26 - $119.0 $7.57 Million - $10.4 Million
-87,815 Reduced 64.33%
48,690 $4.55 Million
Q3 2021

Nov 12, 2021

SELL
$100.17 - $126.36 $1.3 Million - $1.64 Million
-12,989 Reduced 8.69%
136,505 $15.2 Million
Q2 2021

Jul 23, 2021

BUY
$86.05 - $119.72 $12.9 Million - $17.9 Million
149,494 New
149,494 $17 Million
Q1 2021

May 10, 2021

SELL
$91.47 - $124.36 $186,598 - $253,694
-2,040 Closed
0 $0
Q4 2020

Feb 24, 2021

SELL
$66.66 - $111.74 $666 - $1,117
-10 Reduced 0.49%
2,040 $203,000
Q4 2020

Feb 12, 2021

BUY
$66.66 - $111.74 $136,653 - $229,067
2,050 New
2,050 $203,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.